Abstract
Neurodegeneration in multiple sclerosis: retinal imaging as a biomarker Current treatment strategies for multiple sclerosis (MS) are immunomodulatory by preventing activation, proliferation, or extravasation of immune cells into the central nervous system (i.e. brain, spinal cord, and optic nerve). Here Associate Professor Tara M. DeSilva explains how therapeutic strategies reduce the number of relapses and improve the quality of life early in the disease course, nevertheless, neurodegeneration ultimately gives rise to permanent disability (1).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
